Mvm Partners, Llc Sells 10,835 Shares of Paragon 28, Inc. (NYSE:FNA) Stock

Paragon 28, Inc. (NYSE:FNA) major shareholder Mvm Partners, Llc sold 10,835 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $10.09, for a total value of $109,325.15. Following the completion of the transaction, the insider now owns 10,548,230 shares in the company, valued at $106,431,640.70. The trade was a 0.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Mvm Partners, Llc also recently made the following trade(s):

• On Friday, November 22nd, Mvm Partners, Llc sold 72,133 shares of Paragon 28 stock. The stock was sold at an average price of $10.16, for a total value of $732,871.28.
• On Wednesday, November 20th, Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock. The stock was sold at an average price of $10.28, for a total value of $1,517,132.68.

Paragon 28 Stock Performance

Shares of FNA stock opened at $9.98 on Wednesday. The business’s 50-day moving average price is $6.83 and its 200-day moving average price is $7.24. Paragon 28, Inc. has a 12 month low of $4.65 and a 12 month high of $14.79. The firm has a market capitalization of $835.53 million, a price-to-earnings ratio of -13.49 and a beta of 1.01. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79.

Paragon 28 (NYSE:FNA) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.01. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The firm had revenue of $62.30 million for the quarter, compared to analyst estimates of $60.58 million. During the same period last year, the firm posted ($0.10) earnings per share. The business’s revenue for the quarter was up 18.0% on a year-over-year basis. Equities research analysts forecast that Paragon 28, Inc. will post -0.66 EPS for the current year.

Institutional Trading of Paragon 28

A number of hedge funds have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its stake in shares of Paragon 28 by 16.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company’s stock valued at $156,000 after purchasing an additional 1,766 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Paragon 28 by 9.0% during the second quarter. The Manufacturers Life Insurance Company now owns 25,992 shares of the company’s stock worth $178,000 after acquiring an additional 2,142 shares during the last quarter. Rhumbline Advisers raised its position in shares of Paragon 28 by 6.0% during the second quarter. Rhumbline Advisers now owns 65,727 shares of the company’s stock worth $450,000 after acquiring an additional 3,720 shares during the last quarter. Commerce Bank raised its position in shares of Paragon 28 by 28.5% during the third quarter. Commerce Bank now owns 18,350 shares of the company’s stock worth $123,000 after acquiring an additional 4,075 shares during the last quarter. Finally, Algert Global LLC raised its position in shares of Paragon 28 by 12.0% during the second quarter. Algert Global LLC now owns 38,793 shares of the company’s stock worth $265,000 after acquiring an additional 4,157 shares during the last quarter. 63.57% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

FNA has been the topic of a number of recent analyst reports. Piper Sandler reaffirmed an “overweight” rating and issued a $12.00 price objective (down from $15.00) on shares of Paragon 28 in a research note on Friday, August 9th. Canaccord Genuity Group reduced their price objective on Paragon 28 from $17.00 to $15.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Finally, Needham & Company LLC raised their price objective on Paragon 28 from $11.00 to $13.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $15.60.

About Paragon 28

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.